Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shalini Asthana, Pramod K Gupta, Mohini Chaurasia, Anuradha Dube & Manish K Chourasia. (2013) Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos. Expert Opinion on Drug Delivery 10:12, pages 1633-1651.
Read now
Read now
Articles from other publishers (19)
João Guilherme Lino da Silva, Ana Alice Maia Gonçalves, Liliam Teixeira Oliveira, Giani Martins Garcia, Maurício Azevedo Batista, Ludmila Zanandreis de Mendonça, Kelvinson Fernandes Viana, Rita de Cássia Oliveira Sant’Ana, Otoni Alves de Oliveira Melo Júnior, Denise Silveira-Lemos, Walderez Ornelas Dutra, Olindo Assis Martins-Filho, Alexsandro Sobreira Galdino, Sandra Aparecida Lima de Moura, Vanessa Carla Furtado Mosqueira & Rodolfo Cordeiro Giunchetti. (2023) Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity. Vaccines 11:8, pages 1309.
Crossref
Crossref
Marco Antonio Cabrera González, Ana Alice Maia Gonçalves, Jennifer Ottino, Jaqueline Costa Leite, Lucilene Aparecida Resende, Otoni Alves Melo-Júnior, Patrícia Silveira, Mariana Santos Cardoso, Ricardo Toshio Fujiwara, Lilian Lacerda Bueno, Renato Lima Santos, Tatiane Furtado de Carvalho, Giani Martins Garcia, Paulo Ricardo de Oliveira Paes, Alexsandro Sobreira Galdino, Miguel Angel Chávez-Fumagalli, Marília Martins Melo, Denise Silveira-Lemos, Olindo Assis Martins-Filho, Walderez Ornelas Dutra, Vanessa Carla Furtado Mosqueira & Rodolfo Cordeiro Giunchetti. (2023) Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster. Vaccines 11:1, pages 111.
Crossref
Crossref
Sana Ayari-Riabi, Noureddine Ben khalaf, Balkiss Bouhaouala-Zahar, Bernard Verrier, Thomas Trimaille, Zakaria Benlasfar, Mehdi Chenik & Mohamed Elayeb. (2022) Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major. Molecules 27:24, pages 8677.
Crossref
Crossref
Jennifer Ottino, Jaqueline Costa Leite, Otoni Alves Melo-Júnior, Marco Antonio Cabrera González, Tatiane Furtado de Carvalho, Giani Martins Garcia, Maurício Azevedo Batista, Patrícia Silveira, Mariana Santos Cardoso, Lilian Lacerda Bueno, Ricardo Toshio Fujiwara, Renato Lima Santos, Paulo Ricardo de Oliveira Paes, Denise Silveira-Lemos, Olindo Assis Martins-Filho, Alexsandro Sobreira Galdino, Miguel Angel Chávez-Fumagalli, Walderez Ornelas Dutra, Vanessa Carla Furtado Mosqueira & Rodolfo Cordeiro Giunchetti. (2022) Nanoformulations with Leishmania braziliensis Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (Mesocricetus auratus) against Visceral Leishmaniasis. Vaccines 10:11, pages 1848.
Crossref
Crossref
Pragya Prasanna, Prakash Kumar, Saurabh Kumar, Vinod Kumar Rajana, Vishnu Kant, Surendra Rajit Prasad, Utpal Mohan, V. Ravichandiran & Debabrata Mandal. (2021) Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review. Biomedicine & Pharmacotherapy 141, pages 111920.
Crossref
Crossref
Olga Kammona & Evgenia Tsanaktsidou. (2021) Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. International Journal of Pharmaceutics 605, pages 120761.
Crossref
Crossref
Laysa Rocha Lima, Fabia Karine Andrade, Daniela Ribeiro Alves, Selene Maia de Morais & Rodrigo Silveira Vieira. (2021) Anti-acetylcholinesterase and toxicity against Artemia salina of chitosan microparticles loaded with essential oils of Cymbopogon flexuosus, Pelargonium x ssp and Copaifera officinalis. International Journal of Biological Macromolecules 167, pages 1361-1370.
Crossref
Crossref
Kuldeep Rajpoot. (2019) Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery. Current Pharmaceutical Design 25:37, pages 3943-3959.
Crossref
Crossref
Yashdeep Phanse, Brenda R. Carrillo-Conde, Amanda E. Ramer-Tait, Rajarshi Roychoudhury, Scott Broderick, Nicola Pohl, Krishna Rajan, Balaji Narasimhan, Michael J. Wannemuehler & Bryan H. Bellaire. (2017) Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants. Journal of Biomedical Materials Research Part A 105:10, pages 2762-2771.
Crossref
Crossref
Negar Seyed, Tahereh Taheri & Sima Rafati. (2016) Post-Genomics and Vaccine Improvement for Leishmania. Frontiers in Microbiology 7.
Crossref
Crossref
. 2016. Controlled Release Systems. Controlled Release Systems
441
464
.
Víctor Gutiérrez, Amedea B. Seabra, Rosa M. Reguera, Jayant Khandare & Marcelo Calderón. (2016) New approaches from nanomedicine for treating leishmaniasis. Chemical Society Reviews 45:1, pages 152-168.
Crossref
Crossref
Maria Jose Morilla & Eder Lilia Romero. 2015. Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases. Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases
297
317
.
Ayman M. Gebril, Dimitrios A. Lamprou, Manal M. Alsaadi, William H. Stimson, Alexander B. Mullen & Valerie A. Ferro. (2014) Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 10:5, pages e971-e979.
Crossref
Crossref
Claudia Carbone, Antonio Leonardi, Sarha Cupri, Giovanni Puglisi & Rosario Pignatello. (2014) Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharmaceutical Patent Analyst 3:2, pages 199-215.
Crossref
Crossref
Zichao Luo, Ping Li, Jizhe Deng, Ningning Gao, Yijuan Zhang, Hong Pan, Lanlan Liu, Ce Wang, Lintao Cai & Yifan Ma. (2013) Cationic polypeptide micelle-based antigen delivery system: A simple and robust adjuvant to improve vaccine efficacy. Journal of Controlled Release 170:2, pages 259-267.
Crossref
Crossref
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour & Mahmoud Reza Jaafari. (2013) Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends. Vaccine 31:5, pages 735-749.
Crossref
Crossref
Volker Gerdts, George Mutwiri, James Richards, Sylvia van Drunen Littel-van den Hurk & Andrew A. Potter. (2013) Carrier molecules for use in veterinary vaccines. Vaccine 31:4, pages 596-602.
Crossref
Crossref
Christine Rueckert & Carlos A. Guzmán. (2012) Vaccines: From Empirical Development to Rational Design. PLoS Pathogens 8:11, pages e1003001.
Crossref
Crossref